Spero Therapeutics, Inc. Operating Leases, Future Minimum Payments, Remainder of Fiscal Year
Spero Therapeutics, Inc. (SPRO) had Operating Leases, Future Minimum Payments, Remainder of Fiscal Year of $248.00 thousand as of 2018-09-30, per its 10-Q filed 2018-11-08.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear · last filed 2018-11-08
- 2018-09-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $248.00K.
- 2018-06-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $453.00K.
- 2018-03-31: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $658.00K.
- 2017-09-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $201.00K.
| Period end | Operating Leases, Future Minimum Payments, Remainder of Fiscal Year |
|---|---|
| 2018-09-30 | $248.00K 10-Q · filed 2018-11-08 |
| 2018-06-30 | $453.00K 10-Q · filed 2018-08-09 |
| 2018-03-31 | $658.00K 10-Q · filed 2018-05-10 |
| 2017-09-30 | $201.00K 10-Q · filed 2017-12-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 |